Panbela Therapeutics Inc (PBLA)
0.41
-0.03
(-6.82%)
USD |
OTCM |
Apr 26, 16:00
Panbela Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2014 | -0.501M |
| September 30, 2014 | -0.1418M |
| June 30, 2014 | -0.0464M |
| March 31, 2014 | -0.0411M |
| December 31, 2013 | -0.0051M |
| Date | Value |
|---|---|
| September 30, 2013 | 0.1394M |
| June 30, 2013 | 0.077M |
| March 31, 2013 | 0.0342M |
| December 31, 2012 | 0.0191M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Processa Pharmaceuticals Inc | -- |
| Fate Therapeutics Inc | 112.66M |
| Ardelyx Inc | -131.25M |
| Checkpoint Therapeutics Inc | -- |
| Palisade Bio Inc | -- |